Division of Viral Immunology, Centers for AIDS Research, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan.
Hum Immunol. 2010 Feb;71(2):123-7. doi: 10.1016/j.humimm.2009.10.015. Epub 2009 Nov 3.
Most escape mutations have been identified on cytotoxic T lymphocyte (CTL) epitopes presented by Caucasian or African human leukocyte antigen (HLA) class I alleles, whereas a limited number of studies have identified the escape mutations on epitopes presented by Asian alleles. HLA-B54 is a common HLA allele in Asian countries. We recently identified five HLA-B5401-restricted HIV-1-specific CTL epitopes. We here investigated escape mutations in these CTL epitopes in Japanese HIV-1-infected individuals. The frequency of substitution from Glu (E) to Asp (D) at position 7 (FV9-7D) in the Pol 154-162 (FV9) epitope was significantly higher in HLA-B5401(+) HIV-infected individuals than in HLA-B5401(-) individuals, whereas substitutions that were significantly higher in HLA-B5401(+) individuals than in HLA-B5401(-) individuals were not found in the other four epitopes. FV9-specific CTLs showed reduced killing activity against target cells pulsed with the FV9-7D mutant peptide and failed to kill those infected with the FV9-7D mutant virus, strongly suggesting that FV9-7D is an escape mutant. Furthermore, longitudinal sequence analysis of the FV9 epitope in two HLA-B5401(+) individuals revealed that the sequence had changed from the wild type to the FV9-7D during the clinical course. Taken together, these results indicate that the FV9-7D escape mutant had been selected by FV9-specific CTLs among chronically HIV-1-infected HLA-B*5401(+) individuals.
大多数逃逸突变已在细胞毒性 T 淋巴细胞(CTL)表位中被鉴定出来,这些表位由白种人或非洲人类白细胞抗原(HLA)I 类等位基因呈递,而少数研究已经鉴定出由亚洲等位基因呈递的表位的逃逸突变。HLA-B54 是亚洲国家常见的 HLA 等位基因。我们最近鉴定了五个由 HLA-B5401 限制的 HIV-1 特异性 CTL 表位。我们在此研究了日本 HIV-1 感染个体中这些 CTL 表位的逃逸突变。在 Pol 154-162(FV9)表位中,位置 7(FV9-7D)处谷氨酸(E)突变为天冬氨酸(D)的取代频率在 HLA-B5401(+)HIV 感染个体中明显高于 HLA-B5401(-)个体,而在其他四个表位中,HLA-B5401(+)个体中的取代频率明显高于 HLA-B5401(-)个体的情况并未发现。FV9 特异性 CTL 对用 FV9-7D 突变肽脉冲的靶细胞的杀伤活性降低,并且未能杀伤感染 FV9-7D 突变病毒的细胞,强烈表明 FV9-7D 是逃逸突变体。此外,对两个 HLA-B5401(+)个体中 FV9 表位的纵向序列分析显示,在临床过程中,该序列已从野生型变为 FV9-7D。总之,这些结果表明,在慢性 HIV-1 感染的 HLA-B*5401(+)个体中,FV9 特异性 CTL 选择了 FV9-7D 逃逸突变体。